80 FR 10201 - In the Matter of Akesis Pharmaceuticals, Inc., Stellar Resources, Ltd., and Thwapr, Inc.; Order of Suspension of Trading

SECURITIES AND EXCHANGE COMMISSION

Federal Register Volume 80, Issue 37 (February 25, 2015)

[Federal Register Volume 80, Number 37 (Wednesday, February 25, 2015)]
[Notices]
[Page 10201]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-03874]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Akesis Pharmaceuticals, Inc., Stellar Resources, 
Ltd., and Thwapr, Inc.; Order of Suspension of Trading

February 20, 2015.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Akesis Pharmaceuticals, Inc. because it has not filed any periodic 
reports since the period ended September 30, 2008.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Stellar Resources, Ltd. because it has not filed any periodic reports 
since the period ended January 31, 2012.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Thwapr, Inc. because it has not filed any periodic reports since the 
period ended June 30, 2012.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed companies is suspended for the period from 9:30 a.m. EST 
on February 20, 2015, through 11:59 p.m. EST on March 5, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-03874 Filed 2-24-15; 8:45 am]
BILLING CODE 8011-01-P